Vasculoprotective effects of oestrogens

Area of Science:

• Cardiovascular Research
• Endocrinology
• Immunology

Background:

• Epidemiological data show women's protection against atherosclerosis complications before menopause.
• This protective effect, linked to sex hormones, diminishes post-menopause.
• Oestrogen's atheroprotective effects are consistently observed in animal models.

Purpose of the Study:

• To review the pathophysiology of atherosclerosis.
• To detail oestradiol's (E2) targets in the vessel wall: endothelium and inflammatory-immune cells.
• To discuss potential mechanisms for hormone-replacement therapy's lack of effect in the Heart and Estrogen/progestin Replacement Study (HERS).

Main Methods:

• Literature review of atherosclerosis pathophysiology.
• Analysis of oestradiol's cellular targets.
• Discussion of hormone replacement therapy outcomes.

Main Results:

• Oestradiol targets both the endothelium and inflammatory-immune cells.
• Understanding these targets is crucial for explaining therapeutic outcomes.
• Unknown mechanisms may underlie the HERS trial results.

Conclusions:

• Oestrogen's role in atherosclerosis is complex, involving vascular and immune systems.
• Further research is needed to elucidate mechanisms behind hormone therapy efficacy.
• Understanding oestrogen's targets may guide future cardiovascular disease prevention strategies.